Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This refers to a complex biochemical process rather than a discrete therapeutic target. Nitric oxide (NO) can be generated from nitrite through multiple pathways involving various enzymes and proteins. Key mechanisms include: deoxyhemoglobin and deoxymyoglobin acting as nitrite reductases that reduce nitrite to NO under hypoxic conditions[2]; the di-iron protein YtfE functioning as a high-affinity nitrite reductase in bacteria[3]; and various heme-containing enzymes that catalyze nitrite reduction along oxygen gradients[2]. The process involves complex redox chemistry where nitrite interacts with reduced heme groups or metal centers to produce NO. This NO generation from nitrite represents an alternative to the classical L-arginine-dependent NO synthase pathway and is particularly important under low oxygen conditions. The process is relevant to nitrosative stress, signaling, and various pathophysiological conditions, but it is not a single molecular target that can be modulated by drugs in the traditional sense.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nitric oxide release from nitrite and nitrosated proteins.